• 1
    Aggett P. Iron and women in the reproductive years. In: The British Nutrition Foundation’s Task Force, editors. Iron: Nutritional and Physiological Significance, 1st edn. London: Chapman and Hall; 1995. p. 1108.
  • 2
    Baker W. Iron deficiency in pregnancy, obstetrics and gynecology. Hematol Oncol Clin North Am 2000;14:106177.
  • 3
    Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:68995.
  • 4
    Kotto-Kome AC, Calhoun DA, Montenegro R, Sosa R, Maldonado L, Christensen MD. Effect of administering recombinant erythropoietin to women with postpartum anemia: a meta-analysis. J Perinatol 2004;24:1115.
  • 5
    Atkinson LA, Baxley EG. Postpartum fatigue. Am Fam Physician 1994;50:11318.
  • 6
    Silverman JA, Barrett J, Callum JL. The appropriateness of red blood cell transfusions in the peripartum patient. Obstet Gynecol 2004;104:10004.
  • 7
    Morrison JC, Morrison FG. Rational use of blood products in obstetrics and gynecology. J Matern Fetal Invest 1994;4:14753.
  • 8
    Hallberg L, Ryttinger L, Solvell L. Side effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl 1966;459:310.
  • 9
    Solvell L. Oral iron therapy-side effects. In: HallbergL, HarwerthHG, VannottiA, editors. Iron Deficiency: Pathogenesis, Clinical Aspects, Therapy, 1st edn. London: Academic Press; 1970. p. 57383.
  • 10
    Perewunsnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr 2002;88:310.
  • 11
    Mei Z, Cogswell ME, Parvanta I, Lynch S, Beard JL, Stoltzfus RJ, Grummer-Strawn LM. Haemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomised controlled trials. J Nutr 2005;135:197480.
  • 12
    Van Den Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: which measurements are valid? Br J Haematol 1998;103:81724.
  • 13
    Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, et al. Pharmacokinetics and red cell utilization of iron (III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol 1999;104:296302.
  • 14
    Danielson B. Intravenous iron therapy-efficacy and safety of iron sucrose. In: HuchA, HuchR, BreymannC, editors. Prevention and Management of Anemia in Pregnancy and Postpartum Haemorrhage. Zurich, Switzerland: Schellenberg Druck AG, 1998. p. 93106.
  • 15
    Danielson B, Salmonson T, Derendorf H, Geisser P. Pharmacokinetics of iron hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Drug Res 1996;46:61521.
  • 16
    Breymann C. Modern therapy concepts for severe anemia in pregnancy and postpartum. In: HuchA, HuchR, BreymannC, editors. Prevention and Management of Anemia in Pregnancy and Postpartum Haemorrhage. Zurich, Switzerland: Schellenberg Druck AG, 1998. p. 10722.
  • 17
    Al-Momen AK, Al-Meshari A, Al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;69:1214.
  • 18
    Stoltzfus RJ. Iron-deficiency anemia: re-examining the nature and magnitude of the public health problem. Summary: implication for research and programs. J Nutr 2001;131:697S700S.
  • 19
    Corwin EJ, Murray-Kolb LE, Beard JL. Low haemoglobin is a risk factor for postpartum depression. J Nutr 2003;133:413942.
  • 20
    Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet 2003;361:1619.
  • 21
    NHS Executive. Better Blood Transfusion Appropriate Use of Blood, (Circular HSC 2002/009). London: NHS Executive, 2002.